{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:11:29Z","timestamp":1791994289750,"version":"4.4.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.urolonc.2020.09.029","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T12:45:00Z","timestamp":1602765900000},"page":"74.e9-74.e16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Site of metastatic recurrence impacts prognosis in patients with high-grade upper tract urothelial carcinoma"],"prefix":"10.1016","volume":"39","author":[{"given":"Joseph G.","family":"Cheaib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren E.","family":"Claus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiten D.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max R.","family":"Kates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Matoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah M.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinity J.","family":"Bivalacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean H.","family":"Hoffman-Censits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip M.","family":"Pierorazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.urolonc.2020.09.029_bib0001","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1464-410X.2010.09675.x","article-title":"Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005","volume":"107","author":"Raman","year":"2011","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.urolonc.2020.09.029_bib0002","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","article-title":"European association of urology guidelines on upper urinary tract urothelial carcinoma: 2017 update","volume":"73","author":"Roupr\u00eat","year":"2018","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2020.09.029_bib0003","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.eururo.2014.03.003","article-title":"A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma","volume":"66","author":"Leow","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.09.029_bib0004","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(20)30415-3","article-title":"Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomized controlled trial","volume":"395","author":"Birtle","year":"2020","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.urolonc.2020.09.029_bib0005","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/cncr.28655","article-title":"Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma","volume":"120","author":"Porten","year":"2014","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.urolonc.2020.09.029_bib0006","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/cncr.24135","article-title":"Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration","volume":"115","author":"Margulis","year":"2009","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.urolonc.2020.09.029_bib0007","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.urolonc.2019.06.009","article-title":"Preoperative predictive model and nomogram for disease recurrence following radical nephroureterectomy for high grade upper tract urothelial carcinoma","volume":"37","author":"Freifeld","year":"2019","journal-title":"Urol Oncol"},{"issue":"3","key":"10.1016\/j.urolonc.2020.09.029_bib0008","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.juro.2016.09.078","article-title":"Postoperative nomogram for relapse-free survival in patients with high grade upper tract urothelial carcinoma","volume":"197","author":"Krabbe","year":"2017","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2020.09.029_bib0009","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.urolonc.2013.11.006","article-title":"Effect of tumor size on recurrence-free survival of upper tract urothelial carcinoma following surgical resection","volume":"32","author":"Espiritu","year":"2014","journal-title":"Urol Oncol"},{"issue":"13","key":"10.1016\/j.urolonc.2020.09.029_bib0010","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1245\/s10434-012-2499-8","article-title":"Risk of cancer-specific mortality following recurrence after radical nephroureterectomy","volume":"19","author":"Rink","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.urolonc.2020.09.029_bib0011","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10585-018-9884-z","article-title":"How do organ-specific metastases affect prognosis and surgical treatment for patients with metastatic upper tract urothelial carcinoma: first evidence from population based data","volume":"34","author":"Dong","year":"2017","journal-title":"Clin Exp Metastasis"},{"issue":"6","key":"10.1016\/j.urolonc.2020.09.029_bib0012","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.juro.2015.06.077","article-title":"Patterns of lymphatic metastases in upper tract urothelial carcinoma and proposed dissection templates","volume":"194","author":"Matin","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.09.029_bib0013","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.1038\/srep06361","article-title":"The impact of tumor location and multifocality on prognosis for patients with upper tract urothelial carcinoma: a meta-analysis","volume":"4","author":"Wu","year":"2014","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.urolonc.2020.09.029_bib0014","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.eururo.2015.02.003","article-title":"Recurrence patterns after open and robot-assisted radical cystectomy for bladder cancer","volume":"68","author":"Nguyen","year":"2015","journal-title":"Eur Urol"},{"issue":"12","key":"10.1016\/j.urolonc.2020.09.029_bib0015","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.urolonc.2016.06.013","article-title":"Lymph node yield and tumor location in upper tract urothelial carcinoma patients undergoing nephroureterectomy impacts survival: a U.S. population based analysis (2004-2012)","volume":"34","author":"Chappidi","year":"2016","journal-title":"Urol Oncol"},{"issue":"4S","key":"10.1016\/j.urolonc.2020.09.029_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.juro.2018.03.098","article-title":"LBA26 phase ii trial of neoadjuvant chemotherapy followed by extirpative surgery for patients with High Grade Upper Tract Urothelial Carcinoma (HG UTUC): results from ECOG-ACRIN 8141","volume":"199","author":"Hoffman-Censits","year":"2018","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2020.09.029_bib0017","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.juro.2012.10.065","article-title":"Prognostic risk stratification of patients with urothelial carcinoma of the bladder with recurrence after radical cystectomy","volume":"189","author":"Nakagawa","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.09.029_bib0018","series-title":"Renal cell carcinoma: current clinical oncology","first-page":"147","article-title":"Prognostic factors in metastatic renal cell carcinoma","author":"Elson","year":"2000"},{"issue":"9","key":"10.1016\/j.urolonc.2020.09.029_bib0019","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1007\/s00268-017-4024-5","article-title":"Patterns and outcomes of recurrent esophageal cancer after curative esophagectomy","volume":"41","author":"Yamashita","year":"2017","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.urolonc.2020.09.029_bib0020","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.crad.2006.06.015","article-title":"Recurrent endometrial cancer: patterns of recurrent disease and assessment of prognosis","volume":"62","author":"Sohaib","year":"2007","journal-title":"Clin Radiol"},{"issue":"3","key":"10.1016\/j.urolonc.2020.09.029_bib0021","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4174\/astr.2014.86.3.143","article-title":"Predictive factors and the prognosis of recurrence of colorectal cancer within 2 years after curative resection","volume":"86","author":"Ryuk","year":"2014","journal-title":"Ann Surg Treat Res"},{"issue":"4","key":"10.1016\/j.urolonc.2020.09.029_bib0022","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ejso.2006.09.005","article-title":"The significance of the site of recurrence to subsequent breast cancer survival","volume":"33","author":"Imkampe","year":"2007","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2020.09.029_bib0023","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.athoracsur.2006.08.046","article-title":"Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection","volume":"83","author":"Sugimura","year":"2007","journal-title":"Ann Thorac Surg"},{"issue":"13","key":"10.1016\/j.urolonc.2020.09.029_bib0024","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1002\/cncr.25836","article-title":"Survival after complete surgical resection of multiple metastases from renal cell carcinoma","volume":"117","author":"Alt","year":"2011","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.urolonc.2020.09.029_bib0025","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ejca.2010.11.036","article-title":"Survival after recurrent osteosarcoma: data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials","volume":"47","author":"Gelderblom","year":"2011","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.urolonc.2020.09.029_bib0026","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ijrobp.2017.03.029","article-title":"Prognosticimportance of the site of recurrence in patients with metastatic recurrent cervical cancer","volume":"98","author":"Kim","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"10.1016\/j.urolonc.2020.09.029_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206400","article-title":"A multi-gene expression profile panel for predicting liver metastasis: an algorithmic approach","volume":"13","author":"Shah","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.urolonc.2020.09.029_bib0028","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2174\/1566524017666170807144946","article-title":"Gene expression meta-analysis of potential metastatic breast cancer markers","volume":"17","author":"Bell","year":"2017","journal-title":"Curr Mol Med"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920304658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920304658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:20:47Z","timestamp":1761042047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143920304658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1078143920304658"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.09.029","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Site of metastatic recurrence impacts prognosis in patients with high-grade upper tract urothelial carcinoma","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.09.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}